SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-12-368964
Filing Date
2012-08-27
Accepted
2012-08-27 08:34:38
Documents
7
Effectiveness Date
2012-08-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d383481ddefm14a.htm DEFM14A 1555450
2 GRAPHIC g383481g23c65.jpg GRAPHIC 168519
3 GRAPHIC g383481g41d20.jpg GRAPHIC 165062
4 GRAPHIC g383481g43s80.jpg GRAPHIC 15124
5 GRAPHIC g383481g45x78.jpg GRAPHIC 8815
6 GRAPHIC g383481g46x98.jpg GRAPHIC 145833
7 GRAPHIC g383481g84t56.jpg GRAPHIC 7820
  Complete submission text file 0001193125-12-368964.txt   2261726
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-10827 | Film No.: 121055699
SIC: 2834 Pharmaceutical Preparations